News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Actavis Reports Net Profit of EUR27 Million in 1Q
May 8, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
REYKJAVIK, Iceland, May 8, 2007 (PRIME NEWSWIRE) -- Actavis Group (OMX:ACT), the international generic pharmaceuticals company, today announced results for the first quarter ending 31 March 2007.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Company closure
Bespoke Startup EveryONE Folds 1 Week After Plausible Mechanism Guidance
March 4, 2026
·
2 min read
·
Tristan Manalac
Layoff Tracker
Theravance Halves Headcount, Cans R&D Work After Phase 3 Fail
March 4, 2026
·
61 min read
·
BioSpace Editorial Staff
Earnings
Keytruda Hangs On to Best Seller Crown as GLP-1s Gain Ground
March 4, 2026
·
9 min read
·
Tristan Manalac
MASH
Boehringer Ingelheim Axes MASH Pact With OSE After Disappointing Mid-Stage Data
March 3, 2026
·
2 min read
·
Tristan Manalac